(Acetato-κO)(acetato-κ²O,O')[2-(3,5-di-methyl-1H-pyrazol-1-yl-κN²)quinoline-κN]zinc(II).

The Zn(II) atom in the title compound, [Zn(C₂H₃O₂)₂(C₁₄H₁₃N₃)], is coordinated by an N₂O₃ donor set defined by the quinolinyl- and pyrazolyl-N atoms of the chelating heterocyclic ligand, and three carboxyl-ate-O atoms derived from the monodentate and bidentate carboxyl-ate ligands. Distortions from the ideal square-pyramidal coordination geometry relate to the restricted bite angle of the chelating ligands, i.e. O-Zn-O = 59.65 (5) and N-Zn-N = 76.50 (6)°, and the close approach of the non-coordinating carbonyl atom [Zn⋯O = 2.858 (2) Å]. In the crystal, mol-ecules are consolidated into a three-dimensional architecture by C-H⋯O inter-actions.